• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多组学分析揭示代谢功能障碍相关脂肪性肝病中的跨界肠道生态失调。

Multi-omic analysis reveals transkingdom gut dysbiosis in metabolic dysfunction-associated steatotic liver disease.

作者信息

Kim Hanseul, Nelson Paul, Nzabarushimana Etienne, Shen Jiaxian, Jensen Jordan, Bhosle Amrisha, Li Chengchen, Lee Nawon, Everett Christine, Berdy Brittany, Frongillo Giana, Livny Jonathan, Hu Frank B, Simon Tracey G, McIver Lauren, Franzosa Eric A, Chan Andrew T, Hayete Boris, Thompson Kelsey N, Huttenhower Curtis, Nguyen Long H

机构信息

Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, USA.

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

出版信息

Nat Metab. 2025 Jul 2. doi: 10.1038/s42255-025-01318-6.

DOI:10.1038/s42255-025-01318-6
PMID:40604156
Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common condition linked to obesity and the metabolic syndrome, yet its transkingdom connections have been under-investigated. We performed high-resolution multi-omic profiling-including stool metagenomes, metatranscriptomes and metabolomes-in 211 MASLD cases and 502 controls from a cohort of female nurses. Here we show that MASLD is associated with shifts in 66 gut bacterial species, including widespread enrichment of oral-typical microbes, and transkingdom dysbiosis involving not only bacterial but also viral taxa. Streptococcus spp. are more abundant in non-lean versus lean MASLD, the latter being a paradoxical subtype of a disease typically associated with increased adiposity. These microbial changes correspond with shifts in transcripts and metabolites, including increases in polyamines and acylcarnitines and reductions in secondary bile acids. We highlight gut viral perturbations in MASLD, showing that expansions of bacteriophage targeting oral-typical bacteria correspond to expansions of their bacterial hosts in the gut. We provide a comprehensive resource for understanding MASLD and highlight transkingdom multi-omic microbial shifts as potential contributors to its aetiopathogenesis.

摘要

代谢功能障碍相关脂肪性肝病(MASLD)是一种与肥胖和代谢综合征相关的常见疾病,但其跨领域联系尚未得到充分研究。我们对来自一组女性护士的211例MASLD病例和502例对照进行了高分辨率多组学分析,包括粪便宏基因组、宏转录组和代谢组。我们发现,MASLD与66种肠道细菌种类的变化有关,包括口腔典型微生物的广泛富集,以及不仅涉及细菌而且涉及病毒类群的跨领域生态失调。在非瘦型与瘦型MASLD中,链球菌属更为丰富,后者是一种通常与肥胖增加相关疾病的矛盾亚型。这些微生物变化与转录本和代谢物的变化相对应,包括多胺和酰基肉碱增加以及次级胆汁酸减少。我们强调了MASLD中肠道病毒的扰动,表明靶向口腔典型细菌的噬菌体扩增与其在肠道中的细菌宿主扩增相对应。我们提供了一个全面的资源来理解MASLD,并强调跨领域多组学微生物变化是其发病机制的潜在促成因素。

相似文献

1
Multi-omic analysis reveals transkingdom gut dysbiosis in metabolic dysfunction-associated steatotic liver disease.多组学分析揭示代谢功能障碍相关脂肪性肝病中的跨界肠道生态失调。
Nat Metab. 2025 Jul 2. doi: 10.1038/s42255-025-01318-6.
2
Gut-Liver Axis: The Role of Intestinal Microbiota and Their Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease.肠-肝轴:肠道微生物群及其代谢产物在代谢功能障碍相关脂肪性肝病进展中的作用
Gut Liver. 2025 May 8. doi: 10.5009/gnl240539.
3
Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease in Rats via Gut Microbiota Remodeling and Inflammatory Suppression.通过肠道微生物群重塑和炎症抑制改善大鼠代谢功能障碍相关脂肪性肝病
Nutrients. 2025 Jun 16;17(12):2013. doi: 10.3390/nu17122013.
4
Alisol B ameliorated metabolic dysfunction-associated steatotic liver disease via regulating purine metabolism and restoring the gut microbiota disorders.泽泻醇B通过调节嘌呤代谢和恢复肠道微生物群紊乱改善代谢功能障碍相关脂肪性肝病。
Phytomedicine. 2025 Jun 22;145:156992. doi: 10.1016/j.phymed.2025.156992.
5
ameliorates progression of steatotic liver disease by regulating bile acid, lipid, inflammation and proliferation.通过调节胆汁酸、脂质、炎症和增殖来改善脂肪性肝病的进展。
Gut Microbes. 2025 Dec;17(1):2539448. doi: 10.1080/19490976.2025.2539448. Epub 2025 Aug 3.
6
Microbiota encroachment and a gut-adipose-liver axis in metabolic dysfunction-associated steatotic liver disease.微生物群入侵与代谢功能障碍相关脂肪性肝病中的肠-脂肪-肝轴
Am J Physiol Gastrointest Liver Physiol. 2025 Jul 1;329(1):G201-G214. doi: 10.1152/ajpgi.00381.2024. Epub 2025 May 16.
7
Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass.代谢功能障碍相关脂肪性肝病:肌肉与体重的故事。
World J Gastroenterol. 2025 May 28;31(20):105346. doi: 10.3748/wjg.v31.i20.105346.
8
The Association Between and Advanced Fibrosis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病进展过程中[具体内容缺失]与晚期肝纤维化的关联。
Nutrients. 2025 Jun 27;17(13):2145. doi: 10.3390/nu17132145.
9
Multi-Cohort Exploration of Repetitive Element Transcription and DNA Methylation in Human Steatotic Liver Disease.人类脂肪性肝病中重复元件转录和DNA甲基化的多队列探索
Int J Mol Sci. 2025 Jun 8;26(12):5494. doi: 10.3390/ijms26125494.
10
The human gut microbiome and its metabolic pathway dynamics before and during HIV antiretroviral therapy.人类肠道微生物群及其在HIV抗逆转录病毒治疗之前和期间的代谢途径动态变化。
Microbiol Spectr. 2025 Aug 5;13(8):e0220524. doi: 10.1128/spectrum.02205-24. Epub 2025 Jun 16.

引用本文的文献

1
Cysteine deficiency induces rapid weight loss via adipose tissue browning.半胱氨酸缺乏通过脂肪组织褐变诱导体重快速下降。
Nat Rev Endocrinol. 2025 Aug;21(8):458. doi: 10.1038/s41574-025-01146-4.

本文引用的文献

1
Microbial metabolites as modulators of host physiology.微生物代谢物作为宿主生理学的调节剂。
Adv Microb Physiol. 2024;84:83-133. doi: 10.1016/bs.ampbs.2023.12.001. Epub 2024 Jan 16.
2
Altered Microbial Transcription in Long-term Proton Pump Inhibitor Use: Findings From a United States Cohort Study.长期使用质子泵抑制剂导致的微生物转录改变:一项美国队列研究的结果
Gastroenterology. 2024 Jul;167(2):405-408.e3. doi: 10.1053/j.gastro.2024.03.026. Epub 2024 Mar 21.
3
Integrated annotation prioritizes metabolites with bioactivity in inflammatory bowel disease.
综合注释优先考虑具有生物活性的代谢物在炎症性肠病中的作用。
Mol Syst Biol. 2024 Apr;20(4):338-361. doi: 10.1038/s44320-024-00027-8. Epub 2024 Mar 11.
4
The gut ileal mucosal virome is disturbed in patients with Crohn's disease and exacerbates intestinal inflammation in mice.肠回肠黏膜病毒组在克罗恩病患者中受到干扰,并在小鼠中加剧肠道炎症。
Nat Commun. 2024 Feb 22;15(1):1638. doi: 10.1038/s41467-024-45794-y.
5
Machine learning and deep learning applications in microbiome research.机器学习与深度学习在微生物组研究中的应用。
ISME Commun. 2022 Oct 6;2(1):98. doi: 10.1038/s43705-022-00182-9.
6
Enterobacteriaceae Growth Promotion by Intestinal Acylcarnitines, a Biomarker of Dysbiosis in Inflammatory Bowel Disease.肠杆菌科通过肠道酰基肉碱的生长促进作用,炎症性肠病中菌群失调的生物标志物。
Cell Mol Gastroenterol Hepatol. 2024;17(1):131-148. doi: 10.1016/j.jcmgh.2023.09.005. Epub 2023 Sep 20.
7
Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes.肠道微生物组的改变提示炎症性关节炎表型中关键分类群和代谢途径的存在。
Sci Transl Med. 2023 Jul 26;15(706):eabn4722. doi: 10.1126/scitranslmed.abn4722.
8
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家组关于新的脂肪肝疾病命名的德尔菲共识声明。
J Hepatol. 2023 Dec;79(6):1542-1556. doi: 10.1016/j.jhep.2023.06.003. Epub 2023 Jun 24.
9
iPHoP: An integrated machine learning framework to maximize host prediction for metagenome-derived viruses of archaea and bacteria.iPHoP:一种集成机器学习框架,用于最大化基于宏基因组的古菌和细菌病毒的宿主预测。
PLoS Biol. 2023 Apr 21;21(4):e3002083. doi: 10.1371/journal.pbio.3002083. eCollection 2023 Apr.
10
Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4.利用 MetaPhlAn 4 对未鉴定物种进行宏基因组分类分析的扩展和改进。
Nat Biotechnol. 2023 Nov;41(11):1633-1644. doi: 10.1038/s41587-023-01688-w. Epub 2023 Feb 23.